Výsledky vyhledávání - "Takehiko MURAKAMI"

Autor: Takehiko Murakami

Publikováno v: Journal of Japan Institute of Electronics Packaging. 10:514-517

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::954dc7e847697cbbe102476a591e8c02
https://doi.org/10.5104/jiep.10.514

Zobrazit plný text záznamu

Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy

Autor: Eisuke Tsuda, Kazuo Motoyoshi, N. Fujise, Kanji Higashio, Katsuhiro Ono, Naokazu Nagata, Mikio Yamamoto, S.-I. Mochizuki, Takehiko Murakami, Takuhiko Akatsu, Masami Nishikawa

Publikováno v: Bone. 23:495-498

Osteoclastogenesis inhibitory factor (OCIF) is a novel secreted protein that inhibits osteoclastogenesis both in vitro and in vivo. In this study, we examined the effects of OCIF on serum calcium (Ca) concentrations in normal mice and in hypercalcemi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26bcb9c2470ffdb19f1f3574d52374ac
https://doi.org/10.1016/s8756-3282(98)00141-0

Zobrazit plný text záznamu

Transforming Growth Factor-β1 Increases mRNA Levels of Osteoclastogenesis Inhibitory Factor in Osteoblastic/Stromal Cells and Inhibits the Survival of Murine Osteoclast-like Cells

Autor: Mikio Yamamoto, Takuhiko Akatsu, Katsuhiro Ono, Naokazu Nagata, Kazuo Motoyoshi, Takehiko Murakami, Michiko Yamamoto, Miyuki Nishikawa

Publikováno v: Biochemical and Biophysical Research Communications. 252:747-752

Osteoclastogenesis inhibitory factor (OCIF), also termed osteoprotegerin (OPG), is a secreted member of the tumor necrosis factor (TNF) receptor family. It inhibits bone resorption in vivo and osteoclast-like cell (OCL) formation in vitro. To better

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5386ca6cf6a179c7b7315bab09597401
https://doi.org/10.1006/bbrc.1998.9723

Zobrazit plný text záznamu

Osteoclastogenesis Inhibitory Factor Suppresses Osteoclast Survival by Interfering in the Interaction of Stromal Cells with Osteoclast

Autor: Nariyoshi Shinomiya, Takehiko Murakami, Miyuki Nishikawa, Kanji Higashio, Kyoji Yamaguchi, Takuhiko Akatsu, Michiko Yamamoto, Eisuke Tsuda, Kazuo Motoyoshi, Katsuhiro Ono, Shinichi Mochizuki, Naokazu Nagata, Masahiko Kinosaki

Publikováno v: Biochemical and Biophysical Research Communications. 250:229-234

Osteoclastogenesis inhibitory factor (OCIF) was originally identified as a factor inhibiting osteoclast (OC) formation. The number of OC in rats treated with OCIF decreased, suggesting that OCIF inhibits OC formation in vivo; however, it is also poss

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a37368ccf0481229a0db78d5d3dfa50
https://doi.org/10.1006/bbrc.1998.9294

Zobrazit plný text záznamu

Hypocalcemic Effect of Osteoclastogenesis Inhibitory Factor/Osteoprotegerin in the Thyroparathyroidectomized Rat

Autor: Kanji Higashio, Takuhiko Akatsu, Naokazu Nagata, Kazuo Motoyoshi, Michiko Yamamoto, Eisuke Tsuda, Miyuki Nishikawa, Shinichi Mochizuki, Takehiko Murakami

Publikováno v: Endocrinology. 139:4012-4015

Osteoclastogenesis inhibitory factor (OCIF), also termed as osteoprotegerin (OPG), is a soluble member of the tumor necrosis factor receptor family. Although OCIF/OPG is shown to inhibit osteoclast formation in vitro and prevent ovariectomy-induced b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e2b0cff0e4a5f79b7bacd0d1a3bb552
https://doi.org/10.1210/endo.139.9.6290

Zobrazit plný text záznamu

Chinese Hamster Ovary Cells Expressing α4β1 Integrin Stimulate Osteoclast Formation In Vitro

Autor: Michiko Yamamoto, Yoshikazu Takada, Naokazu Nagata, Takuhiko Akatsu, Takehiko Murakami, Nobuo Kugai, Katsuhiro Ono, Miyuki Nishikawa, Yasuyuki Katayama, Nariaki Matsuura, Seiki Wada

Publikováno v: Journal of Bone and Mineral Research. 13:1251-1259

It is reported that Chinese hamster ovary cells transfected with human alpha4 cDNA (alpha4CHOs) and expressing functional alpha4beta1 integrin developed bone metasasis in nude mice. To clarify the role of alpha4beta1 integrin in bone metastasis, in t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2260a6204330d55b488983cbdd577920
https://doi.org/10.1359/jbmr.1998.13.8.1251

Zobrazit plný text záznamu

Mouse Mammary Carcinoma Cell Line (BALB/c-MC) Stimulates Osteoclast Formation From Mouse Bone Marrow Cells Through Cell-to-Cell Contact

Autor: Miyuki Nishikawa, Mikio Yamamoto, Takehiko Murakami, Seiki Wada, Katsuhiro Ono, Takuhiko Akatsu, Naokazu Nagata, Nariaki Matsuura, Nobuo Kugai

Publikováno v: Bone. 23:27-32

We recently reported that numerous osteoclasts (OC) were formed in cocultures of some mouse cancer cell lines and bone marrow cells. In this study, we examined mechanisms by which one of the cell lines, BALB/c-MC, induces OC. BALB/c-MC dose dependent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16e56846946d653a4babbd6063ba661e
https://doi.org/10.1016/s8756-3282(98)00065-9

Zobrazit plný text záznamu

A Third-Generation Bisphosphonate, YM175, Inhibits Osteoclast Formation in Murine Cocultures by Inhibiting Proliferation of Precursor Cells via Supporting Cell-Dependent Mechanisms

Autor: Miyuki Nishikawa, Michiko Yamamoto, Takehiko Murakami, Naokazu Nagata, Takuhiko Akatsu, Nobuo Kugai

Publikováno v: Journal of Bone and Mineral Research. 13:986-995

The theory that bisphosphonates inhibit osteoclast formation through their effects on osteoblastic cells remains controversial. To confirm the inhibitory effect of bisphosphonates on osteoclast formation and gain some insights into the underlying mec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448b55f4ffab329bc2f7b249b8aa16a0
https://doi.org/10.1359/jbmr.1998.13.6.986

Zobrazit plný text záznamu

Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic Patients

Autor: Makoto Ayaori, Naotsugu Iwakami, Emi Yakushiji, Bonpei Takase, Maki Iizuka, Makoto Sasaki, Shunichi Takiguchi, Tomohiro Komatsu, Hiroki Sato, Harumi Uto-Kondo, Masatsune Ogura, Kazuhiro Nakaya, Makiko Yogo, Katsunori Ikewaki, Takehiko Murakami

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Background Endothelial dysfunction is an independent predictor for cardiovascular events in patients with type 2 diabetes ( T2DM ). Glucagon like peptide‐1 ( GLP ‐1) reportedly exerts vasodilatory actions, and inhibitors of dipeptidyl peptidase�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5545e502cb7515b100ebdf2a81eb6a62
http://europepmc.org/articles/PMC3603233

Zobrazit plný text záznamu

Thyroid Dysfunction in isolated Adrenocorticotropic Hormone (ACTH) Deficiency: Case Report and Literature Review

Autor: Nobuo Kugai, Naokazu Nagata, Yoko Nemoto, Seiki Wada, Yasuyuki Katayama, Takehiko Murakami

Publikováno v: Endocrine Journal. 40:473-478

A case of isolated ACTH deficiency accompanying transient primary hypothyroidism was reported along with a review of literature on isolated ACTH deficiency in Japan with special reference to its association with thyroid function. Our case, a 56-year-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b9ae28bfcee3d50deab10b41757f0e92
https://doi.org/10.1507/endocrj.40.473

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání